EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma
Antoni Martija(German Cancer Research Center), Stefan Pusch(German Cancer Research Center)
Cited by 15
Related Papers
The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma
|Clinical Cancer Research|2018|84
Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy
|Cell stem cell|2025|55
Characterization of the epithelial membrane protein 3 interaction network reveals a potential functional link to mitogenic signal transduction regulation
|International Journal of Cancer|2019|21
Identification of novel allosteric inhibitors of mutant isocitrate dehydrogenase 1 by cross docking-based virtual screening
|Bioorganic & Medicinal Chemistry Letters|2017|16
Design, synthesis and biological activity of 3-pyrazine-2-yl-oxazolidin-2-ones as novel, potent and selective inhibitors of mutant isocitrate dehydrogenase 1
|Bioorganic & Medicinal Chemistry|2017|14